Taken together, these data show that ALMS1 mutation causes adipose tissue dysfunction, leading to the development of obesity, extreme insulin resistance, and early-onset type 2 diabetes mellitus in ALMS patients. This evidence concerns the gene ALMS1 and Insulin resistance.